Bcl2促进UMR-106细胞BMP-2、OPG表达及补肾健脾活血方对其影响
Bcl2 promotes expression of BMP-2 and OPG and the effect of nourishing kidney, invigorating spleen, and promoting blood flow recipe on the protein expression in UMR-106 cells
  
DOI:10.3969/j.issn.1006.7108.2018.07.001
中文关键词:  补肾健脾活血方  UMR-106细胞  B淋巴细胞瘤-2  过表达/沉默  骨形态发生蛋白2  骨保护素
英文关键词:Nourishing kidney, invigorating spleen, and promoting blood flow recipe  UMR-106  Bcl2  overexpress/silencing  BMP-2  OPG
基金项目:国家自然科学基金项目(81373653,81674004 ,81673786);广东省科技计划项目(2016ZC0096,2016A020216024);广东省自然科学基金项目(2015A030313367);广州市荔湾区科技计划项目(201704041)
作者单位
王吉利1,3 张志海2,3* 黄宏兴2, 3 万雷2, 3 刘海全2, 3柴爽1, 3 汪悦东1, 3 1.广州中医药大学第三临床医学院广东 广州 510006 2.广州中医药大学附属骨伤科医院广东 广州 510405 3.广州中医药大学岭南医学研究中心中医骨伤科学实验室广东 广州 510405 
摘要点击次数: 775
全文下载次数: 480
中文摘要:
      目的 基于构建Bcl2沉默和过表达腺病毒观察Bcl2对成骨细胞骨形态发生蛋白2(bone morphogenetic protein-2,BMP-2)、骨保护素(osteoprotegerin,OPG)蛋白的调节作用及补肾健脾活血方对其影响。方法 将培养的 UMR-106细胞分为空载腺病毒组(沉默Bcl2空载腺病毒 NC-bcl2,过表达Bcl2空载腺病毒 WT-bcl2)、 Bcl2腺病毒组(沉默Bcl2腺病毒 sh-bcl2,过表达Bcl2腺病毒 Ad-bcl2),空载腺病毒+空白血清组(NC-bcl2,WT-bcl2)、空载腺病毒+补肾健脾活血方含药血清组(NC-bcl2+ME,WT-bcl2+ME)、腺病毒+空白血清组(sh-bcl2,Ad-bcl2)、腺病毒+补肾健脾活血方血清组(sh-bcl2+ME,Ad-bcl2+ME),用RT-qPCR检测Bcl2、OPG mRNA的变化、应用免疫印迹( Western Blot)检测Bcl2、OPG、BMP-2的变化。结果 ①荧光倒置显微镜观察包装腺病毒转染UMR-106细胞;②在正常培养基中,与NC-bcl2比较,sh-bcl2 可以降低Bcl2、OPG、BMP-2蛋白的表达(P均<0.05),与WT-bcl2比较,Ad-bcl2可以提高Bcl2、OPG、BMP-2蛋白的表达(P均<0.05);③与NC-bcl2比较,RT-qPCR显示sh-bcl2可以降低Bcl2 mRNA的表达,但OPG mRNA无统计学意义;④在大鼠血清干预中,与空载腺病毒比较,补肾健脾活血方含药血清均可以增加BMP-2、OPG蛋白表达(P均<0.05);在sh-bcl2干预的细胞中,补肾健脾活血方含药血清提高BMP-2、OPG蛋白的表达(P均<0.05);在Ad-bcl2干预的细胞中,中药干预后,BMP-2、OPG未见明显变化。结论 Bcl2可以影响BMP-2、OPG蛋白的表达,补肾健脾活血方可能通过作用于Bcl2影响成骨细胞成骨相关蛋白的表达。
英文摘要:
      Objective By the construction of the silencing and overexpression adenovirus of Bcl2, to obverse the effect Bcl2 on bone morphogenetic protein-2 (BMP-2) and osteoprotegerin (OPG), and the influence of nourishing kidney, invigorating spleen, and promoting blood flow recipe (Recipe). Method UMR-106 cells were divided into vector group (silencing vector Bcl2, NC-bcl2, and overexpression vector Bcl2, WT-bcl2), Bcl2 adenovirus group (silencing Bcl2, sh-bcl2, and overexpression Bcl2, Ad-bcl2), vector adenovirus+blank serum group (NC-bcl2 and WT-bcl2), vector adenovirus+Recipe serum group (NC-bcl2+ME and WT-bcl2+ME), adenovirus+blank serum group (sh-bcl2 and Ad-bcl2), adenovirus+Recipe serum group (sh-bcl2+ME and Ad-bcl2+ME). Bcl2 and OPG mRNA were detected with RT-qPCR. The portion expressions of Bcl2, OPG, and BMP-2 were detected with Western blotting. Results 1) Adenovirus fluorescent in UMR-106 cells was observed with fluorescent inverted microscope. 2) In normal medium, compared with NC-bcl2, sh-bcl2 reduced the protein expressions of Bcl2, OPG, and BMP-2 (P<0.05). Compared with WT-bcl2, the protein expressions of Bcl2, OPG, and BMP-2 were significantly improved in Ad-bcl2 (P <0.05). 3) Compared with NC-bcl2, the mRNA expression of bcl2 decreased in sh-bcl2. However, mRNA expression of OPG had no significance. 4) Compared with vector adenovirus in rat serum intervention, the protein expressions of BMP-2 and OPG increased in Recipe serum (P <0.05). The protein expressions of BMP-2 and OPG increased in the Recipe serum and sh-bcl2 intervention (P<0.05). The protein expressions of BMP-2 and OPG had no significance in Ad-bcl2 intervention. Conclusion Bcl2 could affect the protein expressions of BMP-2 and OPG, and Recipe may affect the osteoclast-related protein expressions through Bcl2.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=D089CC825340B0AF314A9E8868D162DCD55E3A895F16AECC8C93CCAE5338B59653ED5C29997242B7584F8BD638A2D0A9122D11FA2CF40BCE82DB93BE90D08FC3103363770BF3B70C48E88705C9C93FE2AC1AD4FBB81D953FFA991C735ED1380B6F444786CBDDCF2A6EE52204BE25A1A56F3EAFC571C1D0150E809BAB152AF7BD72EF2066BD31155AAABD24ECFD77BB6796CE6DF79A858FB8E0B03D8745DCB3E19F32F7AE1BD2C57BBA895B9EDE9D61C0&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=EA357AD73C8E13BC&aid=2354056DD48CBB456BF15EA4C642EC82&vid=&iid=DF92D298D3FF1E6E&sid=2EA35D7E5C9A6E66&eid=D3D3227EC12877C76B689F87A18CF6D8&fileno=20180701&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="EA357AD73C8E13BC"; var my_aid="2354056DD48CBB456BF15EA4C642EC82";